Chest pain will, of course, remain one of the key manifestations of cardiac disease; however, accuracy of disease identification would be improved if a biomarker or biomarkers for aortic ...
In addition, several circulating biomarkers are useful in the diagnosis and management of heart failure. Cardiac biomarkers, specifically cardiac troponin, are essential for the identification of ...
Ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain has added boost to the <a target=_blan ...
Explore how circulating cell-free plasma telomere length (cf-TL) serves as a promising biomarker for heart failure.
According to this new report, the global cardiac biomarkers testing market is estimated to be valued at US$ 5.7 billion in the year 2028, growing at a CAGR of 8.5% in the period 2020 to 2028. Growth ...
Proton Intelligence Inc., developing the first-ever Continuous Potassium Monitoring (CKM™) platform, today announced the ...
AFICAMTEN was found to be a safe and effective treatment for symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM), ...
Despite this, many issues remain controversial and clinical interpretation can be complex of biomarkers of cardiomyocyte insult. This review assesses the current state of knowledge related to two ...
The pathophysiology of pre-eclampsia has traditionally been thought to result from placental dysfunction; however, a ...
Cardiac biomarkers are measured to determine if people with Type 2 diabetes are at elevated risk for developing heart failure. It is known that weight loss and exercise can reduce risk for ...
Weight loss via lifestyle intervention can change cardiac biomarkers A secondary analysis of the LookAHEAD trial showed that lifestyle interventions targeting weight loss for type 2 diabetes ...